Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography-Reference-Cited by-同舟云学术

Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography

Published:2020 Issue:2 Volume:47 Page:81-91
ISSN:1346-1176
Container-title:Choonpa Igaku
language:en
Short-container-title:Jpn J Med Ultrasonics

Author:

NISHIGORI Shuhei¹,NUMATA Kazushi¹,IRIE Kuniyasu¹,FUKUDA Hiroyuki¹,CHUMA Makoto¹,MAEDA Shin²

Affiliation:

1. Gastroenterological Center, Yokohama City University Medical Center

2. Division of Gastroenterology Yokohama City University Graduate School of Medicine

Publisher

Japan Society of Ultrasonics in Medicine

Subject

Radiology, Nuclear Medicine and imaging

Link

https://www.jstage.jst.go.jp/article/jjmu/47/2/47_JJMU.K.19/_pdf

Reference38 articles.

1. 1) Lencioni R, Cioni D, Crocetti L, et al. Early stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology. 2005;234:961-7.

2. 2) Lau WY, Lai EC. Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int. 2008;7:237-57.

3. 3) Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: current status. World J Radiol. 2010;2:417-24.

4. 4) Bruix J, Sherman M. American association for the study of liver diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020-2.

5. 5) Shiina S, Tateishi R, Arano T, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol. 2012;107: 569-77.